Literature DB >> 33336267

Improved DNA Delivery Efficiency of Bacterial Vectors by Co-Delivery with Exogenous Lipid and Antimicrobial Reagents.

Andrew N Osahor1, Kumaran Narayanan2.   

Abstract

Gene delivery using invasive bacteria as vectors is a robust method that is feasible for plasmid and artificial chromosome DNA construct delivery to human cells presenting β1 integrin receptors. This technique is relatively underutilized owing to the inefficiency of gene transfer to targeted cell populations. Bacterial vectors must successfully adhere to the cell membrane, internalize into the cytoplasm, undergo lysis, and deliver DNA to the nucleus. There are limited studies on the use of exogenous reagents to improve the efficiency of bacteria-mediated gene delivery to mammalian cells. In this chapter, we describe how cationic lipids, conventionally used for DNA and protein transfection, as well as antimicrobial compounds, can be used to synergistically enhance the adherence of invasive bacterial vectors to the cell membrane and improve their predisposition to internalize into the cytoplasm to deliver DNA. Using simple combinatorial methods, functional DNA transfer can be improved by up to four-fold of invaded cell populations. These methods are easy to perform and are likely to be applicable for other bacterial vectors including Listeria and Salmonella.

Entities:  

Keywords:  Bactofection; Cationic lipid; Cell penetrating peptide; E. coli; Gene delivery; Invasion; Transfection efficiency

Mesh:

Substances:

Year:  2021        PMID: 33336267     DOI: 10.1007/978-1-0716-0943-9_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

1.  Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications.

Authors:  Brian Dalby; Sharon Cates; Adam Harris; Elise C Ohki; Mary L Tilkins; Paul J Price; Valentina C Ciccarone
Journal:  Methods       Date:  2004-06       Impact factor: 3.608

Review 2.  Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors.

Authors:  Andrew B Hill; Mingfu Chen; Chih-Kuang Chen; Blaine A Pfeifer; Charles H Jones
Journal:  Trends Biotechnol       Date:  2015-12-23       Impact factor: 19.536

Review 3.  Bacteria in gene therapy: bactofection versus alternative gene therapy.

Authors:  R Pálffy; R Gardlík; J Hodosy; M Behuliak; P Resko; J Radvánský; P Celec
Journal:  Gene Ther       Date:  2006-01       Impact factor: 5.250

4.  Escherichia coli bactofection using Lipofectamine.

Authors:  Kumaran Narayanan; Choon Weng Lee; Aurelian Radu; Edmund Ui Hang Sim
Journal:  Anal Biochem       Date:  2013-04-19       Impact factor: 3.365

5.  In vivo bactofection: listeria can function as a DNA-cancer vaccine.

Authors:  N C Souders; T Verch; Y Paterson
Journal:  DNA Cell Biol       Date:  2006-03       Impact factor: 3.311

Review 6.  Bacterial vectors for imaging and cancer gene therapy: a review.

Authors:  M Cronin; R M Stanton; K P Francis; M Tangney
Journal:  Cancer Gene Ther       Date:  2012-09-21       Impact factor: 5.987

7.  Optimization of 25 kDa linear polyethylenimine for efficient gene delivery.

Authors:  Sun-Hyung Huh; Hyun-Jin Do; Hye-Young Lim; Dong-Ku Kim; Seong-Jun Choi; Hyuk Song; Nam-Hyung Kim; Jin-Ki Park; Won-Kyong Chang; Hyung-Min Chung; Jae-Hwan Kim
Journal:  Biologicals       Date:  2006-11-01       Impact factor: 1.856

8.  Polymyxin B treatment improves bactofection efficacy and reduces cytotoxicity.

Authors:  Charles H Jones; Snehal Rane; Emily Patt; Anitha Ravikrishnan; Chih-Kuang Chen; Chong Cheng; Blaine A Pfeifer
Journal:  Mol Pharm       Date:  2013-10-18       Impact factor: 4.939

9.  DNA Delivery and Genomic Integration into Mammalian Target Cells through Type IV A and B Secretion Systems of Human Pathogens.

Authors:  Dolores L Guzmán-Herrador; Samuel Steiner; Anabel Alperi; Coral González-Prieto; Craig R Roy; Matxalen Llosa
Journal:  Front Microbiol       Date:  2017-08-22       Impact factor: 5.640

Review 10.  Bacterial-directed enzyme prodrug therapy.

Authors:  Panos Lehouritis; Caroline Springer; Mark Tangney
Journal:  J Control Release       Date:  2013-05-17       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.